Results 111 to 120 of about 44,864 (270)

The management of neuroendocrine tumours: A nutritional viewpoint [PDF]

, 2017
Nutritional status in patients with neuroendocrine tumours (NETs), especially of gastroenteropancreatic origin, can be deeply affected by excessive production of gastrointestinal hormones, peptides, and amines, which can lead to malabsorption, diarrhoea,
Annamaria Colao, Antongiulio Faggiano, Genoveffa Pizza, Giovanna Muscogiuri, Luigi Barrea, Marco Gallo, null null, Rosaria Maddalena Ruggeri   +7 more
core   +1 more source

Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome. [PDF]

, 1987
Alessandro Antonelli, Paolo Del Guerra, Alessandra Fierabracci, E. Gori, L Baschieri   +4 more
openalex   +1 more source

Carcinoid heart disease – still a challenging diagnosis?

Romanian Journal of Cardiology
Neuroendocrine tumors (NETs) are rare neoplasms that can occur anywhere in the body. Mostly, they are located in the gastrointestinal tract or lungs. A third of subjects with NETs present carcinoid syndrome (CS) features.
Benchea Laura Cătălina, Anghel Larisa, Sascău Radu Andy, Stătescu Cristian   +3 more
doaj   +1 more source

Síndrome carcinóide – caso clínico

Galicia Clínica, 2017
Os tumores carcinóides são neoplasias raras, mais frequentemente encontradas no trato gastrointestinal, responsáveis pela produção de mediadores neuroendócrinos.
Renata Silva, Ana Cristino, Patrícia Santos, Miguel Moura   +3 more
doaj   +1 more source

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. [PDF]

, 2016
BackgroundEverolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, is used to treat solid tumors and tuberous sclerosis complex (TSC). Stomatitis, an inflammation of the mucous membranes of the mouth, is a common adverse event associated with ...
Anak, O, Franz, D, Gallo, J, Hortobagyi, GN, Motzer, R, Pavel, M, Ravaud, A, Ringeisen, F, Rouyrre, N, Rugo, HS, Yao, J   +10 more
core  

Carcinoid syndrome [PDF]

Canadian Medical Association Journal, 2009
openaire   +3 more sources

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study [PDF]

, 2019
Marianne Pavel, E. Baudin, Kjell E. Öberg, J.D. Hainsworth, M. Voi, N. Rouyrre, M. Peeters, D.J. Gross, J.C. Yao   +8 more
openalex   +1 more source

Ectopic ACTH syndrome in a dog with a mesenteric neuroendocrine tumour: a case report [PDF]

, 2014
Ectopic ACTH secretion is provoked by extra-pituitary tumours that secrete ACTH, constituting an infrequent type of Cushing Syndrome in the dog. Neuroendocrine tumours (NET) are characterised by the synthesis of peptides with hormone activity.
Cabrera Blatter, M. F., Castillo, V. A., Galleli, M. F., García, J. D., Hall, P., Miceli, Diego Daniel, Pessina, P. P.   +6 more
core  

Treatment options for PNET liver metastases. a systematic review [PDF]

, 2018
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor.
Aurello, Paolo, Crovetto, Anna, Debs, Tarek, Mangogna, Livia Maria, Moschetta, Giovanni, Nigri, Giuseppe, Persechino, Raffaello, Petrucciani, Niccolò, Ramacciato, Giovanni   +8 more
core   +1 more source

Cardiac disease and midgut carcinoid syndrome [PDF]

, 2000
G Westberg, Kenneth Caidahl, C.‐H. Bergh, H. Ahlman, Bo Wängberg   +4 more
openalex   +1 more source